A highly infectious and deadly fungus, identified as Candidozyma Auris, is silently escalating within UK hospitals, as revealed by a leaked Government dossier obtained by The Mail on Sunday. This secret memo from the UK Health Security Agency (UKHSA) explicitly warns of 'significant outbreaks' of the pathogen, which has shown an alarming rise in cases, despite worrying 'under-reporting' by the National Health Service (NHS). The 'situational awareness update' within the dossier suggests a critical lack of preparedness within the Health Service to effectively manage this potentially lethal disease.

Candidozyma Auris possesses a dangerous ability to lie dormant for extended periods, surviving on surfaces and human skin without immediate detection. Its lethality manifests when it enters the bloodstream through cuts or scratches, a risk compounded by its increasing resistance to antifungal medications. This makes it particularly deadly for individuals with compromised immune systems. The confidential report includes a map illustrating its widespread presence, having affected 72 hospitals across the UK in the past two years alone.

The World Health Organisation has designated Candidozyma Auris as a 'critical priority fungal pathogen,' underscoring its severe threat, given that it tragically claims the lives of almost 60 percent of those it infects within 90 days. While the UKHSA anticipates a lower mortality rate in the UK, health authorities have consistently refused to disclose information regarding UK deaths attributed to the fungus. Stuart Andrew, a Tory health spokesman, expressed grave concerns over the UKHSA's silence, stating, 'Protecting national health demands honesty and openness about the scale of the risk. Anything less will undermine both public confidence and safety.'

Experts highlight the formidable challenge of eradicating the fungus from hospital environments, with probes detecting its traces on various surfaces, including radiators, windowsills, and medical equipment. In a significant move, the UKHSA elevated Candidozyma Auris to a 'schedule 2' illness in April, marking it as the first fungus to receive such a classification and placing it on par with some of the UK's most serious diseases. The country has recorded almost 500 cases of outbreaks in the last two years. Notably, there is an ongoing 'significant outbreak' at Guy's and St Thomas's Hospital in London, where 222 cases have been identified, though it remains unclear how many of these are invasive bloodstream infections. In just the past 12 weeks, cases have been reported in ten different hospitals.

Rohini Manuel of the UKHSA confirmed that 'UKHSA is working with the NHS to investigate the reasons behind this. Outbreaks in this country are rare but we are supporting a number of trusts to limit the spread of C. auris.' Currently, there is no known vaccine available for Candidozyma Auris, further emphasizing the urgency and severity of this public health crisis.